Advertisement
Advertisement

ANAB

ANAB logo

AnaptysBio, Inc. Common Stock

69.33
USD
Sponsored
+2.37
+3.54%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

69.34

+0.01
+0.01%

AnaptysBio, Inc. Common Stock Profile

About

AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.

Info & Links

CEO

Daniel Faga

Headquarters

10770 WATERIDGE CIRCLE, SUITE 210
SAN DIEGO, CA 92121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.anaptysbio.com

Auditor

KPMG LLP

Share holders

7

Employees

104

AnaptysBio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

2.02B

Enterprise Value

1.78B

Enterprise Value/EBITDA(ttm)

39.04

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

8.40

Price to Book(mrq)

51.00

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-5.64%

Profit Margin(ttm)

-62.38%

Return on Equity(ttm)

-1101.24%

Return on Invested Capital(ttm)

52.71%

Return on Assets(ttm)

-3.59%

Income Statement

Revenue(ttm)

234.60M

Revenue Per Share(ttm)

8.16

Gross Profit(ttm)

234.60M

EBITDA(ttm)3

45.59M

Net Income Available to Common(ttm)

-13.23M

Diluted EPS(ttm)

-0.52

Share Statistics

Beta (5Y Monthly)

0.40

52-Week Change

254.09%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

28.75M

Dividend Yield

0.00%

Float4

19.12M

% Held by Insiders

33.50%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

311.64M

Total Cash Per Share(mrq)

10.84

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

9.07%

Quick Ratio(mrq)

9.07%

Book Value Per Share(mrq)

1.33

Cash Flow

Operating Cash Flow Per Share(ytd)

0.68

Free Cash Flow(ytd)

19.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement